Cyclerion Therapeutics In... (CYCN)

AI Score

Unlock

2.75

0.07 (2.61%)

At close: Apr 17, 2025, 3:58 PM

2.66

-3.39%

After-hours: Apr 17, 2025, 07:11 PM EDT

Cyclerion Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018
Cash & Equivalents	3.23M	2.87M	4.59M	5.7M	7.57M	9.11M	5.64M	7.17M	13.38M	20.41M	30.32M	41.13M	53.96M	62.5M	70.39M	41.43M	54.4M	66.84M	56.46M	67.1M	94.89M	117.03M	141.03M	n/a	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	5.35M	5.35M	5.35M	5.35M	5.35M	5.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	1.86M	1.95M	2.04M	2.13M	2.22M	2.32M	2.41M	2.5M	2.59M	2.68M	6.61M	6.7M	6.38M	6.05M	5.53M	7.73M	7.73M	19K	25K
Receivables	556K	44K	n/a	n/a	n/a	n/a	n/a	96K	96K	227K	227K	227K	100K	158K	n/a	n/a	127K	400K	751K	1.03M	1.47M	1.44M	1.86M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	567K	805K	536K	647K	1.01M	928K	562K	n/a	n/a	816K	1.22M	2.26M	1.87M	1.97M	2.16M	1.78M	n/a	n/a
Other Current Assets	16K	11K	11K	10K	11K	30K	428K	503K	537K	488K	482K	477K	468K	459K	1.83M	1.8M	3.16M	1.67M	89K	136K	2.86M	68K	28K	12K	12K
Total Current Assets	4.22M	3.55M	4.71M	6.01M	8.02M	9.86M	7.11M	8.34M	14.82M	21.66M	31.68M	42.84M	55.46M	63.68M	72.99M	44.45M	58.5M	70.12M	59.56M	70.13M	101.2M	120.71M	144.69M	939K	879K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	1.13M	1.17M	1.22M	1.26M	1.31M	1.37M	1.47M	1.56M	153K	49M	50.27M	54.58M	62.09M	63.85M	79.75M	81.27M	83.08M	8.81M	6.5M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.35M	5.35M	5.35M	5.35M	5.35M	5.35M	2.98M	3.12M	3.26M	3.4M	3.53M	3.69M	3.87M	4.06M	2.74M	55.52M	56.88M	61.28M	68.48M	69.9M	85.28M	89M	90.81M	8.83M	6.52M
Total Assets	9.57M	8.9M	10.06M	11.36M	13.37M	15.21M	10.1M	11.46M	18.08M	25.05M	35.21M	46.52M	59.33M	67.74M	75.73M	99.97M	115.38M	131.4M	128.04M	140.03M	186.48M	209.7M	235.5M	9.77M	7.4M
Account Payables	390K	304K	651K	741K	1.2M	814K	1.86M	3.92M	2.97M	1.65M	2.77M	2.52M	1.83M	1.17M	1.39M	1.09M	1.44M	1.85M	2.59M	1.52M	3.31M	5M	8.78M	5.67M	2.78M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.84M	5.39M	5.1M	8.54M	7.42M	6.18M	6.52M	11.11M	10.8M	12.15M	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.51M	3.51M	3.51M	3.51M	3.51M	3.51M	2.67M	n/a	3.25M	866K	n/a	n/a
Other Current Liabilities	63K	396K	616K	678K	102K	1.5M	2.56M	2.81M	3.99M	5.15M	5.51M	5.63M	7.28M	4.93M	4.07M	4.3M	5.93M	3.38M	2.9M	1.73M	5.05M	1.48M	5.94M	8.75M	7.27M
Total Current Liabilities	725K	700K	1.28M	1.44M	2.09M	2.34M	4.95M	7.53M	7.63M	8.53M	9.85M	9.49M	11.09M	11.36M	10.51M	13.47M	16.95M	16.26M	15.64M	11.44M	18.25M	19.1M	21.92M	17.47M	17.85M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	52K	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.92M	2.97M	1.65M	2.77M	2.52M	1.83M	n/a	n/a	38.07M	38.93M	39.79M	46.29M	47.05M	70.5M	71.41M	72.4M	52K	n/a
Total Liabilities	725K	700K	1.28M	1.44M	2.09M	2.34M	4.95M	7.53M	7.63M	8.53M	9.85M	9.49M	11.09M	11.36M	10.51M	51.53M	55.88M	56.05M	61.94M	58.49M	88.75M	90.51M	94.31M	17.52M	17.85M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.51M	3.51M	44.96M	45.73M	46.43M	52.59M	49.72M	73.92M	74.66M	73.26M	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-267.49M	-268.02M	-267.3M	-265.96M	-264.42M	-262.72M	-270.29M	-266.11M	-259.15M	-251.94M	-241.44M	-228.05M	-215.08M	-204.3M	-193.01M	-176.83M	-163.43M	-144.2M	-125.39M	-105.86M	-85.63M	-59.57M	-32.25M	n/a	n/a
Comprehensive Income	n/a	n/a	n/a	-16K	-12K	-18K	-16K	-19K	-20K	-28K	-25K	-24K	-23K	-26K	-26K	-27K	-27K	-27K	-30K	-18K	-20K	1K	-4K	-16.02M	-15.49M
Shareholders Equity	8.85M	8.2M	8.78M	9.92M	11.29M	12.87M	5.15M	3.92M	10.45M	16.52M	25.36M	37.03M	48.25M	56.39M	65.22M	48.43M	59.49M	75.35M	66.1M	81.54M	97.73M	119.2M	141.19M	-7.75M	-10.45M
Total Investments	5.35M	5.35M	5.35M	5.35M	5.35M	5.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a